COVID-19 Infection Significantly Increases False-Positive HIV Test Results
Background
Fourth-generation human immunodeficiency virus (HIV) tests are crucial for early diagnosis, detecting both HIV antibodies and the p24 antigen (a viral protein). The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has presented numerous diagnostic challenges due to its systemic effects. This study addresses the previously observed, but not well-quantified, phenomenon of how COVID-19 infection might interfere with the accuracy of these critical HIV diagnostic assays.
Results
The study identified a significant increase in false-positive HIV test results among patients with COVID-19. Among the 1,500 COVID-19 positive patients, 25 individuals (representing 1.67%) exhibited false-positive fourth-generation HIV test results. In stark contrast, the 1,500 COVID-19 negative control patients showed only 2 false-positive results (a rate of 0.13%). This indicates a substantial difference in diagnostic accuracy. > The incidence of false-positive fourth-generation HIV tests was 12.8-fold higher in patients actively infected with COVID-19 compared to uninfected controls (p<0.001). This elevated rate was consistent across different age groups and genders.
Why It Matters
This research highlights a critical diagnostic challenge, as an increased rate of false-positive HIV tests can lead to significant patient anxiety, unnecessary follow-up testing, and a strain on healthcare resources. Understanding this interaction is vital for accurate diagnosis and patient management. The findings underscore the need for clinicians to consider recent COVID-19 infection when interpreting reactive HIV screening tests, potentially leading to improved diagnostic algorithms and guidance for confirmatory testing. Further research, including mechanistic studies, is needed to elucidate the underlying immunological reasons for this phenomenon.